Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Gabriel

Showing results (21-30 of 685) with videos related to

Pageof 69
Sort By:
The American Journal of Medicine|October 24, 2008
Cardiovascular morbidity and mortality in rheumatoid arthritisSherine E Gabriel
Nature Clinical Practice. Rheumatology|January 5, 2007
Do antirheumatic drugs increase the risk of acute myocardial infarction?Sherine E Gabriel
Chest|September 9, 2010
"Meaningful use" means process redesignPeter E Gabriel
Current Opinion in Rheumatology|March 1, 1997
Threats to population-based researchS E Gabriel
Arthritis and Rheumatism|June 1, 1994
The sensitivity and specificity of computerized databases for the diagnosis of rheumatoid arthritisS E Gabriel
Archives of Internal Medicine|July 10, 1995
Has the cost-effectiveness of misoprostol been underestimated?S E Gabriel
The Journal of Rheumatology|July 1, 1995
Economic evaluation using mathematical models: the case of misoprostol prophylaxisS E Gabriel
Current Opinion in Rheumatology|May 6, 1998
Epidemiology and health services researchS E Gabriel
The Journal of Rheumatology|July 1, 1991
Is misoprostol prophylaxis indicated for NSAID induced adverse gastrointestinal events? An epidemiologic opinionS E Gabriel
Current Opinion in Rheumatology|March 1, 1996
Update on the epidemiology of the rheumatic diseasesS E Gabriel
Pageof 69

Showing results (21-30 of 685) with videos related to

Sort By:
Pageof 69
The American Journal of Medicine|October 24, 2008
Cardiovascular morbidity and mortality in rheumatoid arthritisSherine E Gabriel
Nature Clinical Practice. Rheumatology|January 5, 2007
Do antirheumatic drugs increase the risk of acute myocardial infarction?Sherine E Gabriel
Chest|September 9, 2010
"Meaningful use" means process redesignPeter E Gabriel
Current Opinion in Rheumatology|March 1, 1997
Threats to population-based researchS E Gabriel
Arthritis and Rheumatism|June 1, 1994
The sensitivity and specificity of computerized databases for the diagnosis of rheumatoid arthritisS E Gabriel
Archives of Internal Medicine|July 10, 1995
Has the cost-effectiveness of misoprostol been underestimated?S E Gabriel
The Journal of Rheumatology|July 1, 1995
Economic evaluation using mathematical models: the case of misoprostol prophylaxisS E Gabriel
Current Opinion in Rheumatology|May 6, 1998
Epidemiology and health services researchS E Gabriel
The Journal of Rheumatology|July 1, 1991
Is misoprostol prophylaxis indicated for NSAID induced adverse gastrointestinal events? An epidemiologic opinionS E Gabriel
Current Opinion in Rheumatology|March 1, 1996
Update on the epidemiology of the rheumatic diseasesS E Gabriel
Pageof 69